[1]
|
M. F. Abdul-Careem, M. Firoz Mian, A. E. Gillgrass, et al., “FimH, a TLR4 Ligand, Induces Innate Antiviral Responses in the Lung Leading to Protection against Lethal Influenza Infection in Mice,” Antiviral Research, Vol. 92, No. 2, 2011, pp. 346-355.
doi:10.1016/j.antiviral.2011.09.004
|
[2]
|
G. Raicevic, M. Najar, K. Pieters, et al., “Inflammation and TLR Ligation Differentially Affect the Osteogenic Potential of Human Mesenchymal Stromal Cells (MSC) Depending on Their Tissue Origin,” Tissue Engineering Part A, Vol. 25, 2012.
|
[3]
|
S. Challa, M. Woelfel, M. Guildford, et al., “Viral Cell Death Inhibitor MC159 Enhances Innate Immunity against Vaccinia Virus Infection,” Journal of Virology, Vol. 84, No. 20, 2010, pp. 10467-10476.
doi:10.1128/JVI.00983-10
|
[4]
|
M. Ramanathan, W. Luo, B. Csóka, et al., “Differential Regulation of HIF-1Alpha Isoforms in Murine Macrophages by TLR4 and Adenosine A2A Receptor Agonists,” Journal of Leukocyte Biology, Vol. 86, No. 3, 2009, pp. 681-689. doi:10.1189/jlb.0109021
|
[5]
|
J. Hu, D. Lou, B. Carow, et al., “LPS Regulates SOCS2 Transcription in a Type I Interferon Dependent AutocrineParacrine Loop,” PLoS One, Vol. 7, No. 1, 2012, Article ID: e30166. doi:10.1371/journal .pone.0030166
|
[6]
|
C. B. Lu, M. J. Yang, L. Luo, et al., “Detection and Typing of Human Papillomavirus by a GeXP Based Multiplex PCR Assay,” Chinese Journal of Experimental and Clinical Virology, Vol. 25, No. 1, 2011, pp. 69-72.
|
[7]
|
E. F. Dunne, M. Sternberg, L. E. Markowitz, et al., “Human Papillomavirus (HPV) 6, 11, 16, and 18 Prevalence among Females in the United States—National Health and Nutrition Examination Survey, 2003-2006: Opportunity to Measure HPV Vaccine Impact?” The Journal of Infectious Diseases, Vol. 204, No. 4, 2011, pp. 562-565.
|
[8]
|
B. S. Bowser, S. Alam and C. Meyers, “Treatment of a Human Papillomavirus Type 31b-Positive Cell Line with Benzo[a]Pyrene Increases Viral Titer through Activation of the Erk1/2 Signaling Pathway,” Journal of Virology, Vol. 85, No. 10, 2011, pp. 4982-4992.
doi:10.1128/JVI.00133-11
|
[9]
|
X. W. Lu, C. Y. Xiao and H. Ye, “The Research Progress on the Correlationship of Cyto Factor and Human Pappiloma Virus to Cervical Cancer,” The Clinical Physician Magazine: Electronic Edition, Vol. 5, No. 14, 2011, pp. 4163-4166.
|
[10]
|
A. M. Chaussé, O. Grépinet, E. Bottreau, et al., “Expression of Toll-Like Receptor 4 and Downstream Effectors in Selected Cecal Cell Subpopulations of Chicks Resistant or Susceptible to Salmonella Carrier State,” Infection and Immunity, Vol. 79, No. 8, 2011, pp. 3445-3454.
doi:10.1128/IAI.00025-11
|
[11]
|
M. Bosmann, V. R. Patel, N. F. Russkamp, et al., “MyD88-Dependent Production of IL-17F Is Modulated by the Anaphylatoxin C5a via the Akt Signaling Pathway,” The FASEB Journal, Vol. 25, No. 12, 2011, pp. 4222-4232.
doi:10.1096/fj.11-191205
|
[12]
|
M. G. De Boer, H. Jolink, C. J. Halkes, et al., “Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation,” PLoS One, Vol. 6, No. 4, 2011, Article ID: e18403.
|
[13]
|
M. Nakamura, J. M. Bodily, M. Beglin, et al., “HypoxiaSpecific Stabilization of HIF-1Alpha by Human Papillomaviruses,” Virology, Vol. 387, No. 2, 2009, pp. 442-448.
doi:10.1016/j.virol.2009.02.036
|
[14]
|
G. Kleveta, K. Borz?cka, M. Zdioruk, et al., “LPS Induces Phosphorylation of Actin-Regulatory Proteins Leading to Actin Reassembly and Macrophage Motility,” Journal of Cellular Biochemistry, Vol. 113, No. 1, 2012, pp. 80-92. doi:10.1002/jcb.23330
|